BRPI0509005A - partìculas de polìmero contendo ingrediente ativo, e, processo para a aplicação de ingredientes ativos - Google Patents

partìculas de polìmero contendo ingrediente ativo, e, processo para a aplicação de ingredientes ativos

Info

Publication number
BRPI0509005A
BRPI0509005A BRPI0509005-9A BRPI0509005A BRPI0509005A BR PI0509005 A BRPI0509005 A BR PI0509005A BR PI0509005 A BRPI0509005 A BR PI0509005A BR PI0509005 A BRPI0509005 A BR PI0509005A
Authority
BR
Brazil
Prior art keywords
active ingredient
polymer particles
particles containing
range
active ingredients
Prior art date
Application number
BRPI0509005-9A
Other languages
English (en)
Inventor
Werner Siol
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BRPI0509005A publication Critical patent/BRPI0509005A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04—Acids; Metal salts or ammonium salts thereof
    • C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/14—Methyl esters, e.g. methyl (meth)acrylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Colloid Chemistry (AREA)

Abstract

PARTìCULAS DE POLìMERO CONTENDO INGREDIENTE ATIVO, E, PROCESSO PARA A APLICAçãO DE INGREDIENTES ATIVOS A invenção refere-se a partículas de polímero contendo ingredientes ativos, que compreendem um polímero de vinila de 10 - 80% em peso de monómeros que compreendem grupos amino e/ou carboxila, insolúveis em uma parte de pH de 0 - 10 e solúveis em uma outra parte da faixa, caracterizada pelo fato de que as ditas partículas de polímero, que contêm ingredientes ativos, compreendem 3 - 1000 partes de ingrediente ativo por parte de polímero de vinila, com um tamanho da partícula na faixa de 20 nm - 8 <109>m e o polímero de vinila é constituído de > 50% em peso de polímeros com um peso molecular <100 000 dáltons.
BRPI0509005-9A 2004-04-05 2005-04-02 partìculas de polìmero contendo ingrediente ativo, e, processo para a aplicação de ingredientes ativos BRPI0509005A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004016685 2004-04-05
PCT/EP2005/003493 WO2005097197A1 (de) 2004-04-05 2005-04-02 Wirkstoffhaltige polymerteilchen

Publications (1)

Publication Number Publication Date
BRPI0509005A true BRPI0509005A (pt) 2007-08-07

Family

ID=34963958

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509005-9A BRPI0509005A (pt) 2004-04-05 2005-04-02 partìculas de polìmero contendo ingrediente ativo, e, processo para a aplicação de ingredientes ativos

Country Status (14)

Country Link
US (1) US20070224274A1 (pt)
EP (1) EP1735006B1 (pt)
JP (1) JP2007531720A (pt)
CN (1) CN100566755C (pt)
AT (1) ATE374044T1 (pt)
BR (1) BRPI0509005A (pt)
CA (1) CA2558853A1 (pt)
DE (1) DE502005001579D1 (pt)
ES (1) ES2292116T3 (pt)
IL (1) IL177777A (pt)
PL (1) PL1735006T3 (pt)
RU (1) RU2363493C2 (pt)
WO (1) WO2005097197A1 (pt)
ZA (1) ZA200609155B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007036494A2 (de) * 2005-09-30 2007-04-05 Basf Se Agrochemische formulierung umfassend wirkstoffhaltige polymerteilchen
DE102008054391B4 (de) 2008-12-08 2019-03-07 Wacker Chemie Ag Partikuläre Zubereitungen mit Dispergierhilfsmitteln und Verfahren zur Herstellung der Zubereitungen
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
JP6283607B2 (ja) 2011-04-07 2018-02-21 ザ プロクター アンド ギャンブル カンパニー ポリアクリレートマイクロカプセルの堆積が増大されたパーソナルクレンジング組成物
CN103458871B (zh) 2011-04-07 2015-05-13 宝洁公司 具有增强的聚丙烯酸酯微胶囊的沉积的调理剂组合物
CN103458858B (zh) 2011-04-07 2016-04-27 宝洁公司 具有增强的聚丙烯酸酯微胶囊的沉积的洗发剂组合物
US20140056981A1 (en) * 2012-08-21 2014-02-27 Centro De Investigacion En Quimica Aplicada Method for producing drug-loaded polymeric nanoparticles by polymerization in presence of drugs
DE102018129419A1 (de) * 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylat-Copolymer für galenische Anwendungen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28316E (en) * 1968-09-03 1975-01-21 Entrapment compositions and processes
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2135072B2 (de) * 1971-07-14 1973-05-24 Verfahren zur erzeugung hochglaenzender oberflaechen auf dekorpapieren
DK143689C (da) * 1975-03-20 1982-03-15 J Kreuter Fremgangsmaade til fremstilling af en adsorberet vaccine
NO141367C (no) * 1976-11-22 1980-02-27 Sintef Framgangsmaate for framstilling av findelte emulsjoner av et litt vannloeselig materiale
DE3116995A1 (de) * 1981-04-29 1982-11-25 Röhm GmbH, 6100 Darmstadt Latex zur immobilisierung von biologisch wirksamen substanzen
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
US5106903A (en) * 1984-12-17 1992-04-21 Lehigh University Preparation of large particle size monodisperse latexes
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4328069A1 (de) * 1993-08-20 1995-02-23 Henning Berlin Gmbh Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
CA2184242C (en) * 1994-02-28 2000-05-02 Jorg Kreuter Drug targeting system, method for preparing same and its use
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
WO1996024377A1 (de) * 1995-02-10 1996-08-15 Christian Noe Partikuläre arzneiform
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
WO1997015680A1 (en) * 1995-10-25 1997-05-01 Octoplus B.V. Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer

Also Published As

Publication number Publication date
ATE374044T1 (de) 2007-10-15
US20070224274A1 (en) 2007-09-27
CN100566755C (zh) 2009-12-09
EP1735006A1 (de) 2006-12-27
IL177777A0 (en) 2006-12-31
ES2292116T3 (es) 2008-03-01
CA2558853A1 (en) 2005-10-20
RU2006139003A (ru) 2008-05-20
WO2005097197A1 (de) 2005-10-20
ZA200609155B (en) 2008-06-25
IL177777A (en) 2010-05-31
DE502005001579D1 (de) 2007-11-08
EP1735006B1 (de) 2007-09-26
PL1735006T3 (pl) 2008-02-29
CN1938049A (zh) 2007-03-28
RU2363493C2 (ru) 2009-08-10
JP2007531720A (ja) 2007-11-08

Similar Documents

Publication Publication Date Title
BRPI0509005A (pt) partìculas de polìmero contendo ingrediente ativo, e, processo para a aplicação de ingredientes ativos
Mahajan et al. Smart polymers: innovations in novel drug delivery
DE69500069D1 (de) Kosmetische oder pharmazeutische Zusammensetzung enthaltende eine wässrige Polymerdispersion
Li et al. Biomimetic stimulus-responsive star diblock gelators
BRPI0509366A (pt) método para remover potássio de um indivìduo animal, formulação farmacêutica, métodos para tratar uma doença e para determinar uma permeabilidade de casca a um ìon, composição farmacêutica, composição de núcleo-casca,e, método para sintetizar um polìmero de alfa-fluroacrilato
WO2007133807A3 (en) Polymers for functional particles
DE60018068D1 (de) Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
BR0116761A (pt) Processo para a preparação de partìculas de resina absorventes de água de polìmeros contendo carboxila reticulados com baixo teor de monÈmero, partìculas obtidas e seu uso
DE602005022862D1 (de) Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung
MXPA06000029A (es) Dispersion polimerica acuosa y uso de la misma en cosmeticos.
ATE521373T1 (de) Knochenzementzusammensetzung
ATE432687T1 (de) Verwendung als verdickungsmittel in der kosmetik, von neutralisierten copolymeren mit schwachen säure- und starken säureeinheiten
CO5540367A2 (es) Composicion de liberacion controlada y metodo para producirla
ATE438385T1 (de) Pharmazeutische zusammensetzung
DE602005015696D1 (de) Resorbierbare biokompatible beschichtungen
DE60326774D1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
ATE422875T1 (de) Verfahren zur behandlung von haar mit einem mizellaren vernetzten copolymer
RS52308B (en) SALT-IRON LONG-TERM PREPARATION AS ACTIVE SUBSTANCES, PREPARATION AND USE PROCESS
DE60334388D1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
Imamura et al. Synthesis of zwitterionic polymers containing a tertiary sulfonium group for protein stabilization
EP1741750A3 (en) Water-soluble amphoteric copolymer, production method thereof, and application thereof
WO2010089763A3 (en) Poly(n-vinyl caprolactam-co-acrylamide) microparticles for controlled release applications
Maltas et al. Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier
WO2002077037A3 (en) Biaryl monomers and dendritic polymers derived therefrom
WO2004046202A3 (de) Bioabbaubare kolloidale partikel, insbesondere für pulmonale applikationen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/51 (2006.01), A61K 9/16 (2006.01), C08F 220